191 related articles for article (PubMed ID: 12754741)
1. Prognostic significance of BRCA1 expression in sporadic breast carcinomas.
Lambie H; Miremadi A; Pinder SE; Bell JA; Wencyk P; Paish EC; Macmillan RD; Ellis IO
J Pathol; 2003 Jun; 200(2):207-13. PubMed ID: 12754741
[TBL] [Abstract][Full Text] [Related]
2. Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers.
Rayoo M; Yan M; Takano EA; Bates GJ; Brown PJ; Banham AH; Fox SB
J Clin Pathol; 2009 Oct; 62(10):896-902. PubMed ID: 19622517
[TBL] [Abstract][Full Text] [Related]
3. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 in non-inherited breast carcinomas (Review).
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Oncol Rep; 2002; 9(6):1329-33. PubMed ID: 12375043
[TBL] [Abstract][Full Text] [Related]
5. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.
Yoshikawa K; Honda K; Inamoto T; Shinohara H; Yamauchi A; Suga K; Okuyama T; Shimada T; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Clin Cancer Res; 1999 Jun; 5(6):1249-61. PubMed ID: 10389907
[TBL] [Abstract][Full Text] [Related]
6. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas.
Wilson CA; Ramos L; Villaseñor MR; Anders KH; Press MF; Clarke K; Karlan B; Chen JJ; Scully R; Livingston D; Zuch RH; Kanter MH; Cohen S; Calzone FJ; Slamon DJ
Nat Genet; 1999 Feb; 21(2):236-40. PubMed ID: 9988281
[TBL] [Abstract][Full Text] [Related]
7. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
Tilanus-Linthorst MM; Alves C; Seynaeve C; Menke-Pluymers MB; Eggermont AM; Brekelmans CT
Br J Surg; 2006 Aug; 93(8):961-8. PubMed ID: 16758466
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.
Gong YP; Yarrow PM; Carmalt HL; Kwun SY; Kennedy CW; Lin BP; Xing PX; Gillett DJ
Eur J Surg Oncol; 2007 May; 33(4):438-43. PubMed ID: 17125961
[TBL] [Abstract][Full Text] [Related]
9. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.
Rakha EA; Pinder SE; Paish EC; Robertson JF; Ellis IO
J Pathol; 2004 Jul; 203(3):754-61. PubMed ID: 15221934
[TBL] [Abstract][Full Text] [Related]
10. Loss of CD59 expression in breast tumours correlates with poor survival.
Madjd Z; Pinder SE; Paish C; Ellis IO; Carmichael J; Durrant LG
J Pathol; 2003 Aug; 200(5):633-9. PubMed ID: 12898600
[TBL] [Abstract][Full Text] [Related]
11. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
[TBL] [Abstract][Full Text] [Related]
12. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas.
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965
[TBL] [Abstract][Full Text] [Related]
13. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.
Chen Y; Knösel T; Kristiansen G; Pietas A; Garber ME; Matsuhashi S; Ozaki I; Petersen I
J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.
Magdinier F; Ribieras S; Lenoir GM; Frappart L; Dante R
Oncogene; 1998 Dec; 17(24):3169-76. PubMed ID: 9872332
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer.
Kühling H; Alm P; Olsson H; Fernö M; Baldetorp B; Parwaresch R; Rudolph P
J Pathol; 2003 Apr; 199(4):424-31. PubMed ID: 12635132
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
[TBL] [Abstract][Full Text] [Related]
18. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.
Brekelmans CT; Tilanus-Linthorst MM; Seynaeve C; vd Ouweland A; Menke-Pluymers MB; Bartels CC; Kriege M; van Geel AN; Burger CW; Eggermont AM; Meijers-Heijboer H; Klijn JG
Eur J Cancer; 2007 Mar; 43(5):867-76. PubMed ID: 17307353
[TBL] [Abstract][Full Text] [Related]
19. Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.
Arnes JB; Brunet JS; Stefansson I; Bégin LR; Wong N; Chappuis PO; Akslen LA; Foulkes WD
Clin Cancer Res; 2005 Jun; 11(11):4003-11. PubMed ID: 15930334
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
